Product Description: Reglitazar is an agonist for peroxisome proliferator-activated receptor α and β (PPAR α and PPAR β), which enhances insulin sensitivity, lowers blood glucose and regulates blood lipid levels[1].
Applications: Metabolism-sugar/lipid metabolism
Formula: C22H20N2O5
References: [1]Ivanov K L, et al., Reductive Knoevenagel Condensation with the Zn–AcOH System[J]. Synthesis, 2021, 53(07): 1285-1291.
CAS Number: 170861-63-9
Molecular Weight: 392.40
Research Area: Metabolic Disease
Target: PPAR